Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for ISRG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 948.40M
March 31, 2026 808.60M
December 31, 2025 730.00M
September 30, 2025 735.60M
June 30, 2025 560.10M
March 31, 2025 465.00M
December 31, 2024 510.60M
September 30, 2024 458.60M
June 30, 2024 311.10M
March 31, 2024 23.50M
December 31, 2023 -207.20M
September 30, 2023 292.10M
June 30, 2023 487.40M
March 31, 2023 177.30M
December 31, 2022 300.20M
September 30, 2022 214.10M
June 30, 2022 316.20M
March 31, 2022 127.90M
December 31, 2021 416.80M
September 30, 2021 433.10M
June 30, 2021 467.00M
March 31, 2021 419.00M
December 31, 2020 565.60M
September 30, 2020 210.20M
June 30, 2020 119.90M
Date Value
March 31, 2020 247.60M
December 31, 2019 410.70M
September 30, 2019 309.60M
June 30, 2019 233.90M
March 31, 2019 218.40M
December 31, 2018 282.60M
September 30, 2018 272.80M
June 30, 2018 186.70M
March 31, 2018 240.10M
December 31, 2017 301.00M
September 30, 2017 302.50M
June 30, 2017 161.20M
March 31, 2017 188.50M
December 31, 2016 307.30M
September 30, 2016 244.50M
June 30, 2016 238.30M
March 31, 2016 198.90M
December 31, 2015 263.70M
September 30, 2015 151.20M
June 30, 2015 171.50M
March 31, 2015 104.50M
December 31, 2014 129.00M
September 30, 2014 136.80M
June 30, 2014 148.00M
March 31, 2014 145.70M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Stryker Corp. 1.059B
Zimmer Biomet Holdings, Inc. 246.00M
Abbott Laboratories 1.991B
Boston Scientific Corp. 1.279B
Globus Medical, Inc. 176.57M